NCT05379985: Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 754 planned
- Started
- 31 May 2022
- Primary completion
- 31 May 2027
- Arms
- Experimental: RMC-6236
- Results
- None posted
- 18 May 2022: Trial registered
- 31 May 2022: Trial started